sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Jul-2014 11:14
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 826-850 out of 860.

<< < 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>

Public Release: 30-Aug-2012
Scientific Reports
Protein impedes microcirculation of malaria-infected red blood cells
MIT-led research team finds that protein significantly reduces infected cells' ability to squeeze through tiny channels compared to healthy cells.
Singapore-MIT ARTC, National Institutes of Health, Korea Advanced Institute of Science and Technology, l'Agence Nationale de la Recherche

Contact: Sarah McDonnell
Massachusetts Institute of Technology

Public Release: 30-Aug-2012
Human and soil bacteria swap antibiotic-resistance genes
Soil bacteria and bacteria that cause human diseases have recently swapped at least seven antibiotic-resistance genes, researchers at Washington University School of Medicine in St. Louis report Aug. 31 in Science.

Contact: Michael C. Purdy
Washington University School of Medicine

Public Release: 29-Aug-2012
Malaria nearly eliminated in Sri Lanka despite decades of conflict
Despite nearly three decades of conflict,Sri Lanka has succeeded in reducing malaria cases by 99.9 percent since 1999 and is on track to eliminate the disease entirely by 2014.
Bill & Melinda Gates Foundation

Contact: Kristen Bole
University of California - San Francisco

Public Release: 29-Aug-2012
Researchers pioneer world's first HIV/AIDS nanomedicines
Scientists at the University of Liverpool are leading a 1.65 million project to produce and test the first nanomedicines for treating HIV/AIDS. The research project, funded by the Engineering and Physical Sciences Research Council, aims to produce cheaper, more effective medicines which have fewer side effects and are easier to give to newborns and children.

Contact: Sarah Stamper
University of Liverpool

Public Release: 28-Aug-2012
Queen's University Belfast wins national environment award
The University won a Green Apple Environment Award for the arsenic-removal water cleansing project, which was carried out by the School of Planning, Architecture and Civil Engineering.

Contact: Anne-Marie Clarke
Queen's University Belfast

Public Release: 28-Aug-2012
Trends in Molecular Medicine
Better vaccines for tuberculosis could save millions of lives
Cases of one of the world's deadliest diseases -- tuberculosis -- are rising at an alarming rate, despite widespread vaccination. Reasons for the ineffectiveness of the vaccine, especially in regions where this infectious disease is endemic, as well as arguments for replacing the existing vaccine with novel synthetic vaccines, are presented in a review published online Aug. 28 in Trends in Molecular Medicine.

Contact: Mary Beth O'Leary
Cell Press

Public Release: 28-Aug-2012
PLOS Medicine
New PLOS collection: Child mortality estimation methods
A sponsored collection of new articles on the methodology for estimation of child mortality was published today in the open-access journal PLOS Medicine, in conjunction with the UN Inter-agency Group for Child Mortality Estimation (IGME) and the Technical Advisory Group (TAG). The collection contains seven peer reviewed articles and introduces the methodological innovations by the TAG and UN IGME in estimating child mortality which are critical to the monitoring of progress toward the MDG goal.
UNICEF, UN Inter-agency Group for Child Mortality Estimation and Technical Advisory Group

Contact: Tessa Wardlaw

Public Release: 23-Aug-2012
Prestigious Royal Society of Tropical Medicine and Hygiene journals join Oxford University Press
The Royal Society of Tropical Medicine and Hygiene's two prestigious journals will join the Oxford University Press collection in a new partnership announced between the organizations.

Contact: Lizzie Shannon-Little
Oxford University Press

Public Release: 22-Aug-2012
Dartmouth medical research closes in on new tuberculosis vaccine
With a resurgence of TB in the developing world, Dartmouth medical science in Hanover, N.H., and Africa is accelerating the development of a new, more effective vaccine.
National Institutes of Health, Dartmouth College

Contact: Amy Olson
Dartmouth College

Public Release: 22-Aug-2012
As TB grows more difficult to control, vaccine candidate to prevent disease enters clinical testing
Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate. The Phase I clinical trial will assess the safety, tolerability and immunogenicity of the vaccine candidate. The study will be conducted by Johnson County Clin-Trials in Lenexa, Kansas. Tuberculosis, which kills more people than any other infectious disease except HIV, has orphaned 10 million children, and costs the global economy an estimated one billion dollars every day.

Contact: Jamie Rosen

Public Release: 22-Aug-2012
Genome Research
Scientists reveal how river blindness worm thrives
Scientists at the University of Liverpool have found that the worm which causes River Blindness survives by using a bacterium to provide energy, as well as help 'trick' the body's immune system into thinking it is fighting a different kind of infection.

Contact: Kate Mizen
University of Liverpool

Public Release: 19-Aug-2012
American Chemical Society's 244th National Meeting & Exposition
New technology combats global pandemic of drug counterfeiting
Drug counterfeiting is so common in some developing countries that patients with serious diseases in Southeast Asia and elsewhere have been more likely to get a fake drug than one with ingredients that really treat their illness, a scientist involved in combating the problem said here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

Contact: Michael Bernstein
American Chemical Society

Public Release: 17-Aug-2012
New book tells story of 10-year-old malaria project
This year marks the tenth anniversary of the announcement of the genome sequence of the deadly human malaria parasite Plasmodium falciparum and its mosquito vector. A new book on malaria by biologist Irwin W. Sherman of the University of California, Riverside tells the story of how the Plasmodium falciparum Genome Project came into being, the people who created it, and the vast cadre of scientists attempting to realize the promise of the 10 year-old project.

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 16-Aug-2012
East meets West to bring improved sanitation and hygiene practices to Vietnam, Cambodia
East Meets West has received a US $10.9 million grant from the Bill & Melinda Gates Foundation to improve sanitation and hygiene practices among the rural poor in Vietnam and Cambodia. In these countries, open defecation and the unsafe disposal of human waste result in an estimated 17,000 deaths annually, 90 percent of which occur in children under age five and US $1.2 billion in economic losses each year.
Bill and Melinda Gates Foundation

Contact: Guillermo Meneses

Public Release: 16-Aug-2012
Journal of Biological Chemistry
Turmeric spices up virus study
Curcumin, found in the popular spice turmeric, stopped the potentially deadly Rift Valley Fever virus from multiplying in infected cells, a new study from George Mason University shows.

Contact: Michele McDonald
George Mason University

Public Release: 16-Aug-2012
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute, a Seattle-based nonprofit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, announce that they have been cleared by the FDA to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
Defense Advanced Research Projects Agency

Contact: Lee Schoentrup
Infectious Disease Research Institute

Public Release: 16-Aug-2012
Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
Immune cells called dendritic cells, which were previously thought to contribute to the onset and development of multiple sclerosis, actually protect against the disease in a mouse model, according to a study published by Cell Press in the August issue of the journal Immunity. These new insights change our fundamental understanding of the origins of multiple sclerosis and could lead to the development of more effective treatments for the disease.

Contact: Lisa Lyons
Cell Press

Public Release: 16-Aug-2012
World's largest tobacco use study: Tobacco control remains major challenge
An international survey of tobacco use in three billion individuals, published in the current issue of the Lancet, demonstrates an urgent need for policy change in low- and middle-income countries, according to the University at Buffalo professor who led the research.

Contact: Ellen Goldbaum
University at Buffalo

Public Release: 16-Aug-2012
Poxviruses defeat antiviral defenses by duplicating a gene
Scientists have discovered that poxviruses, which are responsible for smallpox and other diseases, can adapt to defeat different host antiviral defenses by quickly and temporarily producing multiple copies of a gene that helps the viruses to counter host immunity.

Contact: Phil Sahm
University of Utah Health Sciences

Public Release: 15-Aug-2012
Cell Host & Microbe
Duke scientists discover genetic material in blood cells that may affect malaria parasites
Researchers at Duke University Medical Center may finally have discovered why people with sickle cell disease get milder cases of malaria than individuals who have normal red blood cells. In a finding that has eluded scientists for years, Duke researchers discovered that genetic material in red blood cells may help alter parasite activity via a novel mechanism that alters parasite gene regulation.
Duke Chancellor's Pilot Project, Roche Foundation for Anemia Research, Burroughs Welcome Fund, Doris Duke Charitable Foundation

Contact: Mary Jane Gore
Duke University Medical Center

Public Release: 15-Aug-2012
Alcoholism: Clinical & Experimental Research
Tracking the effects of prenatal alcohol exposure through to 9 years of age
Although studies of alcohol's effects on fetal growth have consistently demonstrated deficits that persist through infancy, the data on long-term postnatal growth from human studies have been inconsistent. A new study of the effects of heavy prenatal alcohol exposure on growth and body composition throughout childhood has found growth restrictions that persist through to nine years of age, as well as a delay in weight gain during infancy, both of which were exacerbated by iron deficiency.
NIH/National Institute on Alcohol Abuse and Alcoholism, NIH/Office of Research

Contact: R. Colin Carter, M.D.
Alcoholism: Clinical & Experimental Research

Public Release: 14-Aug-2012
Nurses as effective as doctors in treatment of HIV patients
Nurse-centered care of HIV patients can be just as safe and effective as care delivered by doctors and has a number of specific health benefits, according to a new study led by the University of East Anglia and the University of Cape Town.
Medical Research Council, Development Cooperation Ireland, Canadian International Development Agency

Contact: Simon Dunford
University of East Anglia

Public Release: 10-Aug-2012
International Journal of Tuberculosis and Lung Disease
New approach of resistant tuberculosis
Scientists of the Antwerp Institute of Tropical Medicine have breathed new life into a forgotten technique and so succeeded in detecting resistant tuberculosis in circumstances where so far this was hardly feasible. Tuberculosis bacilli that have become resistant against our major antibiotics are a serious threat to world health.
Damien Foundation

Contact: prof Bouke De Jong
Institute of Tropical Medicine Antwerp

Public Release: 9-Aug-2012
Journal of the Pediatric Infectious Diseases Society
First antibiotic stewardship probed in the Journal of the Pediatric Infectious Diseases Society
The articles address: Impact of prospective-audit-with-feedback program and clinician attitudes toward program.

Contact: Jodie Klein
Pediatric Infectious Diseases Society

Public Release: 9-Aug-2012
Wastewater key to quenching global thirst, UCI-led review finds
Parched cities and regions across the globe are using sewage effluent and other wastewater in creative ways to augment drinking water, but 4 billion people still do not have adequate supplies, and that number will rise in coming decades. Wildlife, rivers and ecosystems are also being decimated by the ceaseless quest for new water and disposal of waste. Changing human behavior and redoubling use of alternatives are critical to breaking that cycle.

Contact: Janet Wilson
University of California - Irvine

Showing releases 826-850 out of 860.

<< < 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>